CITY THERAPEUTICS, INC.
CTYNext catalyst
No upcoming catalyst in our data
No upcoming FDA decision, filing or trial readout is on file for CTY. That does not mean none is planned.
Get an email about CTY's next catalysts
Track CITY THERAPEUTICS (CTY) and we email you when an FDA date moves, 7 days and 1 day before the decision when the exact day is known, and when it is announced. Free account, no card.
0 upcoming, 0 past
No catalysts found.
Market Overview
Stock performance and key metrics
Therapeutic Anticoagulation
COVID-19
Diacetylmorphine
Opioid Dependence
PLA (Panto+Levoflox+Azithro)
Helicobacter Pylori Gastritis
Vivarin
Narcolepsy
RSV/Flu-01E
Respiratory Synctial Virus Infections
Cal-Mag Butyrate
Gulf War Illness
Combination of Palbociclib and aromatase inhibitor (Letrozole or Anastrozole)
Hormonal Receptors Positive, HER2 Negative, Advanced Breast Cancer
TB/Flu-05E
Tuberculosis
High-Dose Melphalan HCL for Injection (Propylene Glycol-Free)
Multiple Myeloma
| Drug Name | Phase | Indication | Designations | Patent |
|---|---|---|---|---|
Therapeutic Anticoagulation | Phase 3 | COVID-19 | - | - |
Diacetylmorphine | Phase 3 | Opioid Dependence | - | - |
PLA (Panto+Levoflox+Azithro) | Phase 3 | Helicobacter Pylori Gastritis | - | - |
Vivarin | Phase 2 | Narcolepsy | - | - |
RSV/Flu-01E | Phase 2 | Respiratory Synctial Virus Infections | - | - |
Cal-Mag Butyrate | Phase 2 | Gulf War Illness | - | - |
Combination of Palbociclib and aromatase inhibitor (Letrozole or Anastrozole) | Phase 2 | Hormonal Receptors Positive, HER2 Negative, Advanced Breast Cancer | - | - |
TB/Flu-05E | Phase 2 | Tuberculosis | - | - |
High-Dose Melphalan HCL for Injection (Propylene Glycol-Free) | Phase 2 | Multiple Myeloma | - | - |
Source: CatalystAlert database (ClinicalTrials.gov, SEC EDGAR)
Frequently asked questions
What is in CITY THERAPEUTICS, INC.'s drug pipeline?β
CatalystAlert tracks 9 drug candidates in CITY THERAPEUTICS, INC.'s (CTY) pipeline across Phase 3, Phase 2. Its lead program is Diacetylmorphine (Phase 3). Each drug's phase, indication and upcoming catalysts are listed on this page.
When is CITY THERAPEUTICS, INC.'s next FDA catalyst?β
CatalystAlert tracks every upcoming catalyst for CITY THERAPEUTICS, INC. (CTY) β PDUFA decision dates, Phase 1/2/3 trial readouts, FDA advisory committee meetings and NDA/BLA filings β each confidence-rated as confirmed, estimated or AI-detected.
How do I track CTY biotech catalysts?β
Add CTY to your CatalystAlert watchlist for alerts ahead of each catalyst, and follow CITY THERAPEUTICS, INC.'s live catalyst calendar, drug pipeline and clinical-trial timeline on this page β sourced from ClinicalTrials.gov, FDA and SEC filings.
